Pacira BioSciences, Inc. Common Stock

PCRXNASDAQ • USD
36.46 USD
↘ 0.01 (0.01%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

Shares of Pacira BioSciences, Inc. Common Stock (PCRX) are trading at $36.46. Technical and fundamental signals align bullish — technicals rate "Buy" while fundamentals indicate "Buy". This is driven by a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PCRX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$36.46
High?$36.46
Low?$36.46
Prev. Close?$36.46
Volume?0
Avg. Volume?2.2M
Bid / Ask
Bid?$36.43 × 400
Ask?$36.48 × 800
Spread?$0.05
Midpoint?$36.46
Valuation & Ratios
Market Cap?1.5B
Shares Out?40.1M
Float?38.2M
Float %?95.8%
P/E Ratio?38.57
P/B Ratio?2.04
EPS?$0.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Employees
829
Market Cap
1.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2011-02-03
Address
2000 SIERRA POINT PARKWAY
BRISBANE, CA 94005
Phone: 650-242-8052
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
64
Momentum?
77
Short Sent.?
70
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.77Grey
Confidence?75%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.77%Elevated
Short Interest?3.3M
Days to Cover?3.9
Free Float38.2M
Avg Daily Volume855.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?4.68Strong
Quick Ratio?3.65Strong
Cash Ratio?1.96Strong
Debt/Equity?0.41Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
Peers
100
S&P
19
38.6PRICEY▾
P/B?
Peers
100
S&P
73
2.04CHEAP▾
P/S?
Peers
100
S&P
67
1.96CHEAP▾
P/FCF?
Peers
100
S&P
92
8.6CHEAP▾
EV/EBITDA?
Peers
100
S&P
64
12.6FAIR▾
EV/Sales?
Peers
100
S&P
74
2.02CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
20
5.3%FAIR▾
ROA?
Peers
50
S&P
29
3.1%FAIR▾
Cash Flow & Enterprise
FCF?$169.0M
Enterprise Value?$1.5B
Fundamentals ratios updated end of day